U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from MedGen

Items: 1 to 20 of 31

1.
Memory-like differentiation, tumor targeting monoclonal antibodies, and chimeric antigen receptors enhance natural killer cell responses to head and neck cancer
Miriam T. Jacobs, Pamela Wong, Alice Y. Zhou, Michelle Becker-Hapak, Nancy D. Marin, Lynne Marsala, Mark Foster, Jennifer A. Foltz, Celia C. Cubitt, Jennifer Tran, David A. Russler-Germain, Carly Neal, Samantha Kersting-Schadek, Lily Chang, Timfothy Schappe, Patrick Pence, Ethan McClain, Jose P. Zevallos, Jason T Rich, Randal C. Paniello, Ryan S. Jackson c, Patrik Pipkorn, Douglas R. Adkins, Carl J. DeSelm, Melissa M. Berrien-Elliott, Sidharth V. Puram, Todd A. Fehniger
Clin Cancer Res. Author manuscript; available in PMC 2024 Apr 13.
Published in final edited form as: Clin Cancer Res. 2023 Oct 13; 29(20): 4196–4208. doi: 10.1158/1078-0432.CCR-23-0156
PMCID:
PMC10796148
AbstractArticlePDF–2.7M
2.
A Phase II Trial of Nintedanib in Patients with Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma: In-Depth Analysis of Nintedanib Arm from the KCSG HN 15-16 TRIUMPH Trial
Kyoo Hyun Kim, Sun Min Lim, Hee Kyung Ahn, Yun-Gyoo Lee, Keun-Wook Lee, Myung-Ju Ahn, Bhumsuk Keam, Hye Ryun Kim, Hyun Woo Lee, Ho Jung An, Jin-Soo Kim
Cancer Res Treat. 2024 Jan; 56(1): 37–47. Published online 2023 Jul 20. doi: 10.4143/crt.2023.433
PMCID:
PMC10789954
AbstractArticlePDF–1.5M
3.
AIM2 promotes irradiation resistance, migration ability and PD-L1 expression through STAT1/NF-κB activation in oral squamous cell carcinoma
Hui-Wen Chiu, Hsin-Lun Lee, Hsun-Hua Lee, Hsiao-Wei Lu, Kent Yu-Hsien Lin, Yuan-Feng Lin, Che-Hsuan Lin
J Transl Med. 2024; 22: 13. Published online 2024 Jan 3. doi: 10.1186/s12967-023-04825-w
PMCID:
PMC10762966
AbstractArticlePDF–9.1M
4.
The cGAS/STING/IFN-1 Response in Squamous Head and Neck Cancer Cells after Genotoxic Challenges and Abrogation of the ATR-Chk1 and Fanconi Anemia Axis
Sebastian Zahnreich, Soumia El Guerzyfy, Justus Kaufmann, Heinz Schmidberger
Int J Mol Sci. 2023 Oct; 24(19): 14900. Published online 2023 Oct 4. doi: 10.3390/ijms241914900
PMCID:
PMC10573837
AbstractArticlePDF–2.2M
5.
NCBP2 and TFRC are novel prognostic biomarkers in oral squamous cell carcinoma
Rahul Arora, Logan Haynes, Mehul Kumar, Reid McNeil, Jahanshah Ashkani, Steven C. Nakoneshny, T. Wayne Matthews, Shamir Chandarana, Robert D. Hart, Steven J. M. Jones, Joseph C. Dort, Doha Itani, Ayan Chanda, Pinaki Bose
Cancer Gene Ther. 2023; 30(5): 752–765. Published online 2023 Jan 12. doi: 10.1038/s41417-022-00578-8
PMCID:
PMC10191846
AbstractArticlePDF–3.5M
6.
A novel NRF2/ARE inhibitor gossypol induces cytotoxicity and sensitizes chemotherapy responses in chemo-refractory cancer cells
Ya-Chu Tang, Hsin-Huei Chang, Huang-Hui Chen, Jau-Ying Yao, Yu-Tsen Chen, Yung-Jen Chuang, Jang-Yang Chang, Ching-Chuan Kuo
J Food Drug Anal. 2021; 29(4): 638–652. Published online 2021 Dec 15. doi: 10.38212/2224-6614.3376
PMCID:
PMC9931009
AbstractArticlePDF–2.2M
7.
Afatinib and Pembrolizumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (ALPHA Study): A Phase II Study with Biomarker Analysis
Hsiang-Fong Kao, Bin-Chi Liao, Yen-Lin Huang, Huai-Cheng Huang, Chun-Nan Chen, Tseng-Cheng Chen, Yuan-Jing Hong, Ching-Yi Chan, Jean-San Chia, Ruey-Long Hong
Clin Cancer Res. 2022 Apr 14; 28(8): 1560–1571. Published online 2022 Jan 19. doi: 10.1158/1078-0432.CCR-21-3025
PMCID:
PMC9306266
AbstractArticlePDF–1.0M
8.
Adenovirus Encoding Tumor Necrosis Factor Alpha and Interleukin 2 Induces a Tertiary Lymphoid Structure Signature in Immune Checkpoint Inhibitor Refractory Head and Neck Cancer
James H. A. Clubb, Tatiana V. Kudling, Camilla Heiniö, Saru Basnet, Santeri Pakola, Víctor Cervera Carrascón, João Manuel Santos, Dafne C. A. Quixabeira, Riikka Havunen, Suvi Sorsa, Vincent Zheng, Tuula Salo, Leif Bäck, Katri Aro, Sanni Tulokas, Venla Loimu, Akseli Hemminki
Front Immunol. 2022; 13: 794251. Published online 2022 Mar 7. doi: 10.3389/fimmu.2022.794251
PMCID:
PMC8959099
AbstractArticlePDF–12M
9.
Comprehensive Mutational and Phenotypic Characterization of New Metastatic Cutaneous Squamous Cell Carcinoma Cell Lines Reveal Novel Drug Susceptibilities
Jay Perry, Bruce Ashford, Amarinder Singh Thind, Marie-Emilie Gauthier, Elahe Minaei, Gretel Major, Narayanan Gopalakrishna Iyer, Ruta Gupta, Jonathan Clark, Marie Ranson
Int J Mol Sci. 2020 Dec; 21(24): 9536. Published online 2020 Dec 15. doi: 10.3390/ijms21249536
PMCID:
PMC7765308
AbstractArticlePDF–3.6M
10.
Interleukin 6 is increased in preclinical HNSCC models of acquired cetuximab resistance, but is not required for maintenance of resistance
Rachel A. O’Keefe, Neil E. Bhola, David S. Lee, Daniel E. Johnson, Jennifer R. Grandis
PLoS One. 2020; 15(1): e0227261. Published online 2020 Jan 8. doi: 10.1371/journal.pone.0227261
PMCID:
PMC6948745
AbstractArticlePDF–1.7M
11.
Safety, efficacy and tumor mutational burden as a biomarker of overall survival benefit in chemo-refractory gastric cancer treated with toripalimab, a PD-1 antibody in phase Ib/II clinical trial NCT02915432
F Wang, X L Wei, F H Wang, N Xu, L Shen, G H Dai, X L Yuan, Y Chen, S J Yang, J H Shi, X C Hu, X Y Lin, Q Y Zhang, J F Feng, Y Ba, Y P Liu, W Li, Y Q Shu, Y Jiang, Q Li, J W Wang, H Wu, H Feng, S Yao, R H Xu
Ann Oncol. 2019 Sep; 30(9): 1479–1486. Published online 2019 Jun 24. doi: 10.1093/annonc/mdz197
PMCID:
PMC6771223
AbstractArticlePDF–611K
12.
AKR1C1 controls cisplatin-resistance in head and neck squamous cell carcinoma through cross-talk with the STAT1/3 signaling pathway
Wei-Min Chang, Yu-Chan Chang, Yi-Chieh Yang, Sze-Kwan Lin, Peter Mu-Hsin Chang, Michael Hsiao
J Exp Clin Cancer Res. 2019; 38: 245. Published online 2019 Jun 10. doi: 10.1186/s13046-019-1256-2
PMCID:
PMC6558898
AbstractArticlePDF–4.5M
13.
ΔNp63 in squamous cell carcinoma: defining the oncogenic routes affecting epigenetic landscape and tumour microenvironment
Veronica Gatti, Claudia Fierro, Margherita Annicchiarico‐Petruzzelli, Gerry Melino, Angelo Peschiaroli
Mol Oncol. 2019 May; 13(5): 981–1001. Published online 2019 Mar 22. doi: 10.1002/1878-0261.12473
PMCID:
PMC6487733
AbstractArticlePDF–1.3M
14.
Prognostic signature associated with radioresistance in head and neck cancer via transcriptomic and bioinformatic analyses
Guo-Rung You, Ann-Joy Cheng, Li-Yu Lee, Yu-Chen Huang, Hsuan Liu, Yin-Ju Chen, Joseph T. Chang
BMC Cancer. 2019; 19: 64. Published online 2019 Jan 14. doi: 10.1186/s12885-018-5243-3
PMCID:
PMC6332600
AbstractArticlePDF–1.6M
15.
Vemurafenib in patients with BRAFV600E-positive metastatic or unresectable papillary thyroid cancer refractory to radioactive iodine: a non-randomised, multicentre, open-label, phase 2 trial
Marcia S Brose, Maria E Cabanillas, Ezra E W Cohen, Lori J Wirth, Todd Riehl, Huibin Yue, Prof Steven I Sherman, Eric J Sherman
Lancet Oncol. Author manuscript; available in PMC 2017 Jul 28.
Published in final edited form as: Lancet Oncol. 2016 Sep; 17(9): 1272–1282. Published online 2016 Jul 23. doi: 10.1016/S1470-2045(16)30166-8
PMCID:
PMC5532535
AbstractArticlePDF–636K
16.
Identification of Targetable HER2 Aberrations in Head and Neck Squamous Cell Carcinoma
Andrew C. Birkeland, Megan Yanik, Brittny N. Tillman, Megan V. Scott, Susan K. Foltin, Jacqueline E. Mann, Nicole L. Michmerhuizen, Megan L. Ludwig, Morgan M. Sandelski, Christine M. Komarck, Thomas E. Carey, Mark E.P. Prince, Carol R. Bradford, Jonathan B. McHugh, Matthew E. Spector, J. Chad Brenner
JAMA Otolaryngol Head Neck Surg. Author manuscript; available in PMC 2016 Jun 16.
Published in final edited form as: JAMA Otolaryngol Head Neck Surg. 2016 Jun 1; 142(6): 559–567. doi: 10.1001/jamaoto.2016.0335
PMCID:
PMC4911238
AbstractArticlePDF–860K
17.
AXL mediates resistance to PI3Kα inhibition by activating the EGFR/PKC/mTOR axis in head and neck and esophageal squamous cell carcinomas
Moshe Elkabets, Evangelos Pazarentzos, Dejan Juric, Qing Sheng, Raphael A. Pelossof, Samuel Brook, Ana Oaknin Benzaken, Jordi Rodon, Natasha Morse, Jenny Jiacheng Yan, Manway Liu, Rita Das, Yan Chen, Angela Tam, Huiqin Wang, Jinsheng Liang, Joseph M. Gurski, Darcy A. Kerr, Rafael Rosell, Cristina Teixidó, Alan Huang, Ronald A. Ghossein, Neal Rosen, Trever G. Bivona, Maurizio Scaltriti, José Baselga
Cancer Cell. Author manuscript; available in PMC 2016 Apr 13.
Published in final edited form as: Cancer Cell. 2015 Apr 13; 27(4): 533–546. doi: 10.1016/j.ccell.2015.03.010
PMCID:
PMC4398915
AbstractArticlePDF–3.8M
18.
Expression profile and in vitro blockade of programmed death-1 in human papillomavirus–negative head and neck squamous cell carcinoma
Ian-James Malm, Tullia C. Bruno, Juan Fu, Qi Zeng, Janis M. Taube, William Westra, Drew Pardoll, Charles G. Drake, Young J. Kim
Head Neck. Author manuscript; available in PMC 2015 Aug 1.
Published in final edited form as: Head Neck. 2015 Aug; 37(8): 1088–1095. Published online 2014 Sep 16. doi: 10.1002/hed.23706
PMCID:
PMC4390546
AbstractArticlePDF–1.4M
19.
Induction of CD44 Variant 9-Expressing Cancer Stem Cells Might Attenuate the Efficacy of Chemoradioselection and Worsens the Prognosis of Patients with Advanced Head and Neck Cancer
Takeichiro Aso, Mioko Matsuo, Hideyuki Kiyohara, Kenichi Taguchi, Fumihide Rikimaru, Mototsugu Shimokawa, Yuichi Segawa, Yuichiro Higaki, Hirohito Umeno, Tadashi Nakashima, Muneyuki Masuda
PLoS One. 2015; 10(3): e0116596. Published online 2015 Mar 9. doi: 10.1371/journal.pone.0116596
PMCID:
PMC4353624
AbstractArticlePDF–3.9M
20.
CD10 as a novel marker of therapeutic resistance and cancer stem cells in head and neck squamous cell carcinoma
T Fukusumi, H Ishii, M Konno, T Yasui, S Nakahara, Y Takenaka, Y Yamamoto, S Nishikawa, Y Kano, H Ogawa, S Hasegawa, A Hamabe, N Haraguchi, Y Doki, M Mori, H Inohara
Br J Cancer. 2014 Jul 29; 111(3): 506–514. Published online 2014 May 29. doi: 10.1038/bjc.2014.289
PMCID:
PMC4119971
AbstractArticlePDF–1.4M

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center